<DOC>
	<DOCNO>NCT02560584</DOCNO>
	<brief_summary>The purpose study investigate blue light cystoscopy Cysview improve detection tumor patient bladder cancer surveillance cystoscopy , use KARL STORZ D-Light C PDD Flexible Videoscope System . Another purpose investigate Cysview blue light safe effective use repeatedly .</brief_summary>
	<brief_title>A Study Blue Light Flexible Cystoscopy With Cysview Detection Bladder Cancer Surveillance Setting</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<criteria>1 . Patients bladder cancer followup tumor recurrence ( Note : Patients must include first surveillance cystoscopy histologically confirm tumor . The histologically confirm tumor could either TURB surveillance cystoscopy biopsy take tumor confirm histology ) 2 . History one following : Multiple tumor Recurrent tumor High grade tumor ( ) 1 . Gross haematuria . ( Note : Gross haematuria define heavy bladder bleed result significant amount blood urine , may visually limit cystoscopy . Where haematuria light , patient exclude , investigator 's opinion , rinse and/or electrocautery cystoscopy alleviate haematuria limitation cystoscopy ) 2 . Patients undergo inoffice operating room cystoscopy ( Note : Training patient eligible even undergo operate room cystoscopy ) 3 . Patients receive Bacillus CalmetteGu√©rin ( BCG ) immunotherapy intravesical chemotherapy within past 6 week prior procedure 4 . Porphyria 5 . Known allergy hexaminolevulinate hydrochloride similar compound 6 . Pregnancy breastfeeding ( woman childbearing potential must document negative urine pregnancy test study inclusion use adequate contraception study 7 . Participation clinical study investigational drug either concurrently within last 30 day 8 . Patient investigator sub investigator , research assistant , pharmacist , study coordinator , staff relative thereof directly involve conduct protocol 9 . Patients investigator believe unlikely comply protocol , e.g . mental condition render patient unable understand nature , scope , possible consequence participate clinical study , uncooperative attitude unlikelihood completing study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Non-muscle invasive bladder cancer</keyword>
	<keyword>NMIBC</keyword>
	<keyword>Cysview</keyword>
</DOC>